Followers | 43 |
Posts | 8463 |
Boards Moderated | 3 |
Alias Born | 11/23/2003 |
Thursday, May 25, 2017 2:29:44 PM
…The Cosmetic giant..L’Oreal was very, very interested in Protokinetix’s molecule..AAGP to use in their
Cosmetic Empire…. Protokinetix and L’Oreal had an agreement but as the story go…But L’Oreal wanted total control over the molecule..AAGP and the agreement went South and the companies parted ways..
http://www.cosmeticsdesign.com/Formulation-Science/ProtoKinetix-claims-breakthrough-in-anti-aging-research
As the story goes…L’Oreal must have liked what they saw.. I found these two articles on the research that L’Oreal
had funded two different companies to help develop their own type of “Our”(PKTX)Anti-inflammatory molecule.
http://www.cosmeticsdesign.com/Formulation-Science/Ground-breaking-anti-aging-discovery-from-Antarctic-fish-gets-L-Oreal-excited
http://www.cosmeticsdesign-europe.com/Formulation-Science/Industry-falls-in-behind-L-Oreal-s-investment-in-breakthrough-discovery-from-Antarctic-fish
…AFGPs have proven useful in many applications. However, they are limited by their cost (approximately $10,000/gram), instability, and size (2,600 - 24,000 Daltons). Their large size restricts their use in medicine as they are unable to pass through capillaries into interstitial tissue and are unable to reach target cells. Molecules must be less than 600 Daltons to diffuse through the capillaries. In addition, molecules must be less than 1000 Daltons to pass through cell junctions into neighbouring cells and less than 600 Daltons to cross the blood-brain barrier.
.....With these issues in mind Dr. Geraldine-Castelot-Deliencourt invented AAGP ™ to be a smaller, more stable synthetic version of AFGP.
***With that Question in mind…"WHY..PKTX’s Molecule…AAGP"..
..The Answer is(IMHO).. Because….It Works… :+O
....ProtoKinetix Patents:
USA
Patent Number: US 8,394,362B2
Granted: March 12, 2013
Expires: March 12, 2033
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM